(Total Views: 117)
Posted On: 09/22/2021 10:00:49 AM
Post# of 27260

$DVAX News Article - COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial https://marketwirenews.com/news-releases/covi...89931.html


My Twitter: WhyteStocks